STAAR Surgical Company STAA
NASDAQ
| 10/02/2026 | 07/03/2026 | 04/03/2026 | 01/02/2026 | 09/26/2025 | |
|---|---|---|---|---|---|
| Net Income | 100.55% | 104.03% | 70.41% | -298.10% | -542.54% |
| Total Depreciation and Amortization | 2.89% | 0.71% | 1.23% | 20.72% | 51.66% |
| Total Amortization of Deferred Charges | 692.76% | 683.00% | 1,341.51% | -- | -- |
| Total Other Non-Cash Items | -24.11% | 47.51% | 1.68% | 41.60% | 55.06% |
| Change in Net Operating Assets | -510.20% | -503.72% | -3,554.51% | -85.53% | 153.75% |
| Cash from Operations | 172.10% | 88.60% | -329.39% | -317.68% | -163.07% |
| Capital Expenditure | 64.04% | 77.02% | 75.61% | 75.12% | 52.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -199.33% | -147.03% | 187.92% | 245.60% | 1,533.02% |
| Cash from Investing | -228.20% | -332.80% | 132.79% | 178.25% | 367.08% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | 100.00% | 74.55% | 49.39% |
| Issuance of Common Stock | -54.89% | 115.34% | 33.48% | -53.10% | -56.27% |
| Repurchase of Common Stock | 23.10% | -13.63% | -449.39% | -430.30% | -467.36% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.11% | 43.21% | -836.11% | -179.58% | -174.42% |
| Foreign Exchange rate Adjustments | -141.21% | -72.25% | 887.50% | 229.34% | -71.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -450.11% | 27.66% | 18.97% | 123.13% | -66.77% |